MedTrace Logo

Project to Use Community Health Workers to Reduce Maternal Deaths

NCT03024905 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17000

Last updated 2019-08-09

No results posted yet for this study

Summary

The purpose of this trial is to establish if several interventions will help women in rural Tanzania access health care services during pregnancy and at the time of delivery. The interventions include education about the importance of attending antenatal care visits with nurses and facility deliveries, a voucher for transport to access the health facility at the time of delivery, and supplies to be used either at the health facility, or on route if the women does not make it to the health facility.

Conditions

  • Maternal Mortality
  • Access to Health Care

Interventions

BEHAVIORAL

Village meeting and travel vouchers

The interventions are: 1. Village meetings by community health workers to educate women and their families about safe birthing. 2. Vouchers for free transport by motorcycle taxi drivers to access health facility at delivery.

DEVICE

Birth kit with misoprostol

Provision of birth kit with clean delivery supplies (soap, 2 pairs of gloves, 2 cord clamps, surgical blade, and 600 mcg misoprostol for the woman to take immediately after the delivery to prevent postpartum hemorrhage).

Sponsors & Collaborators

  • Ottawa Hospital Research Institute

    collaborator OTHER

  • Shirati KMT Hospital

    collaborator UNKNOWN

  • Bruyère Health Research Institute.

    lead OTHER

Principal Investigators

  • Bwire Chirangi, MPH · Director of Shirati KMT Hospital

  • Gail C Webber, MD, PhD · Bruyère Health Research Institute.

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-16
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • Tanzania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03024905 on ClinicalTrials.gov